- Home
- LGND vs HBI Comparison
LGND vs HBI Comparison
Compare LGND & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- HBI
- Stock Information
- Founded
- LGND 1987
- HBI 1901
- Country
- LGND United States
- HBI United States
- Employees
- LGND 68
- HBI N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- LGND Health Care
- HBI Consumer Discretionary
- Exchange
- LGND Nasdaq
- HBI Nasdaq
- Market Cap
- LGND 2.2B
- HBI 1.9B
- IPO Year
- LGND 1992
- HBI 2006
- Fundamental
- Price
- LGND $163.73
- HBI $6.10
- Analyst Decision
- LGND Strong Buy
- HBI Buy
- Analyst Count
- LGND 8
- HBI 4
- Target Price
- LGND $144.71
- HBI $6.50
- AVG Volume (30 Days)
- LGND 139.7K
- HBI 14.7M
- Earning Date
- LGND 08-05-2025
- HBI 08-07-2025
- Dividend Yield
- LGND N/A
- HBI N/A
- EPS Growth
- LGND N/A
- HBI N/A
- EPS
- LGND N/A
- HBI 0.25
- Revenue
- LGND $181,488,000.00
- HBI $3,540,309,000.00
- Revenue This Year
- LGND $18.41
- HBI $1.61
- Revenue Next Year
- LGND $18.87
- HBI N/A
- P/E Ratio
- LGND N/A
- HBI $24.22
- Revenue Growth
- LGND 53.40
- HBI 2.95
- 52 Week Low
- LGND $81.74
- HBI $3.96
- 52 Week High
- LGND $129.90
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- LGND 74.67
- HBI 61.42
- Support Level
- LGND $158.40
- HBI $6.21
- Resistance Level
- LGND $161.89
- HBI $6.44
- Average True Range (ATR)
- LGND 3.76
- HBI 0.17
- MACD
- LGND -0.07
- HBI -0.03
- Stochastic Oscillator
- LGND 93.80
- HBI 0.89
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.